ストックスクリーナーアプリを入手
53.12
3.08%
-1.69
アフターアワーズ：
53.12
前日終値:
$54.81
開ける：
$54.71
24時間の取引高:
470.48K
Relative Volume:
0.47
時価総額：
$3.08B
収益：
$199.84M
当期純損益:
$-100.06M
株価収益率:
-27.24
EPS:
-1.95
ネットキャッシュフロー:
$-103.57M
1週間 パフォーマンス:
-4.49%
1か月 パフォーマンス:
-2.85%
6か月 パフォーマンス:
-46.38%
1年 パフォーマンス:
-15.68%
1日の値動き範囲:
$52.99
$55.23
1週間の範囲:
$52.42
$55.30
52週間の値動き範囲:
$47.04
$103.81
Procept Biorobotics Corp Stock (PRCT) Company Profile
PRCT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
53.12 | 3.08B | 199.84M | -100.06M | -103.57M | -1.95 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-02 | 開始されました | Morgan Stanley | Overweight |
| 2024-11-14 | 開始されました | Jefferies | Hold |
| 2023-08-11 | 開始されました | Piper Sandler | Overweight |
| 2023-05-31 | 開始されました | William Blair | Outperform |
| 2022-10-31 | 開始されました | BTIG Research | Neutral |
| 2022-10-25 | 開始されました | Truist | Buy |
| 2022-09-02 | 開始されました | Wells Fargo | Overweight |
| 2022-07-15 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | 開始されました | B. Riley Securities | Buy |
| 2021-10-11 | 開始されました | BofA Securities | Buy |
| 2021-10-11 | 開始されました | Cowen | Outperform |
| 2021-10-11 | 開始されました | Goldman | Neutral |
| 2021-10-11 | 開始されました | Guggenheim | Buy |
| 2021-10-11 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Procept Biorobotics Corp (PRCT) 最新ニュース
Stock Performance Spotlight: Procept BioRobotics Corp (PRCT) Ends the Day at 53.11, Down by -0.23 - DWinneX
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Procept BioRobotics Corp (PRCT) expanding its growth trajectory ahead - Sete News
Ready to Jump After Recent Trade: Incyte Corp (INCY) - Sete News
Leerink Partnrs Has Negative Outlook of PRCT Q2 Earnings - Defense World
Market Insight: Procept BioRobotics Corp (PRCT)’s Notable Drop, Closing at 53.98 - DWinneX
William Blair Issues Pessimistic Forecast for PRCT Earnings - Defense World
Did Procept BioRobotics Corp (PRCT) perform well in the last session? - uspostnews.com
Mariner LLC Purchases 2,429 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
PROCEPT BioRobotics Leadership to Present at Four Premier Healthcare Investment Conferences - Stock Titan
Leerink cuts Procept BioRobotics price target to $90, keeps outperform By Investing.com - Investing.com Nigeria
Promising Potential of PROCEPT BioRobotics’ Aquablation Technology in Prostate Cancer Treatment Drives Buy Rating - TipRanks
Leerink cuts Procept BioRobotics price target to $90, keeps outperform - Investing.com
Bank of America Cuts PROCEPT BioRobotics (NASDAQ:PRCT) Price Target to $84.00 - Defense World
Procept BioRobotics Corp [PRCT] Records 50-Day SMA of $58.96 - knoxdaily.com
Procept BioRobotics price target lowered to $84 from $104 at BofA - TipRanks
Closing Figures: Procept BioRobotics Corp (PRCT)’s Negative Finish at 52.56, Down -5.64 - DWinneX
Procept BioRobotics Corp [PRCT] stock Initiated by Morgan Stanley analyst, price target now $105 - dbtnews.com
Where PROCEPT BioRobotics Stands With Analysts - Benzinga
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2025 Earnings Call Transcript - Insider Monkey
Procept BioRobotics (PRCT) Target Price Cut to $84 by BofA Analy - GuruFocus
Procept BioRobotics reports Q1 EPS (45c), consensus (49c) - TipRanks
PROCEPT BioRobotics (NASDAQ:PRCT) Sees Large Volume Increase on Earnings Beat - Defense World
PROCEPT BioRobotics Sees Strong Revenue Growth in Q1 2025 - TipRanks
Earnings call transcript: Procept Biorobotics beats Q1 2025 EPS forecast By Investing.com - Investing.com India
Procept Biorobotics Corp. Reports Strong Q1 Growth Amid Challenges - TipRanks
Procept BioRobotics sees FY25 revenue $323M, consensus $321.67M - TipRanks
Breakthrough BPH Treatment: Experts Reveal Long-Term Aquablation Results at Major Urology Conference - Stock Titan
Morgan Stanley lowers Procept BioRobotics price target, sees buying opportunity - TipRanks
Procept BioRobotics Corp’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - investchronicle.com
PROCEPT BioRobotics (PRCT) Sees Significant Revenue Growth in Q1 2025 - GuruFocus
Procept BioRobotics Corp (NASDAQ:PRCT): It’s all about numbers this morning - uspostnews.com
Nothing is Better Than Procept BioRobotics Corp (PRCT) stock at the moment - Sete News
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates - MSN
Earnings call transcript: Procept Biorobotics beats Q1 2025 EPS forecast - Investing.com
Procept Biorobotics earnings beat by $0.04, revenue topped estimates - Investing.com
Why Procept Biorobotics Shares Are Under Pressure - TipRanks
PROCEPT BioRobotics Reports First Quarter 2025 Financial Results - TradingView
12-Month Price Target For Procept BioRobotics Corp (NASDAQ:PRCT) Now Sits At 105 - Marketing Sentinel
PROCEPT Crushes Q1 Expectations: 55% Revenue Growth, International Sales Double, 2025 Guidance Raised - Stock Titan
LPL Financial LLC Boosts Stake in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Shares Sold by Wells Fargo & Company MN - Defense World
Piper Sandler maintains $100 target on Procept BioRobotics stock By Investing.com - Investing.com Canada
Piper Sandler maintains $100 target on Procept BioRobotics stock - Investing.com Australia
Analysts Set PROCEPT BioRobotics Co. (NASDAQ:PRCT) PT at $91.43 - Defense World
Truist Financial Cuts PROCEPT BioRobotics (NASDAQ:PRCT) Price Target to $70.00 - Defense World
Leading Urologists Join PROCEPT BioRobotics Leadership for Exclusive Investor Insights - Stock Titan
JPMorgan Chase & Co. Lowers Stock Holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Top Companies in Robotic Surgical Instruments (Apr, 2025) - Tracxn
Vanguard Group Inc. Purchases 297,075 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Corebridge Financial Inc. Sells 496 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Procept Biorobotics Corp (PRCT) 財務データ
収益
当期純利益
現金流量
EPS
0.11%
0.79%
大文字化:
|
ボリューム (24 時間):